Two Publications Highlight Clinical Utility of Signatera™ in Anal and Rectal Cancers
Go back to Two Publications Highlight Clinical Utility of Signatera™ in Anal and Rectal Cancers| (NASDAQ: NTRA) | Delayed: 272.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $272.31 | 52 Week High | $13.80 | |||
| Open | $272.31 | 52 Week Low | $6.52 | |||
| Day High | $272.31 | P/E | N/A | |||
| Day Low | $272.31 | EPS | $0.00 | |||
| Volume | 406 | |||||
